Annual General Meeting Addendum Notice and Proxy Form
Released
Released
Announcement PDF
1
7 November 2025
Dear Shareholder,
ANNUAL GENERAL MEETING – NOTICE AND PROXY FORM
Battery Age Minerals Ltd (ASX: BM8; “Battery Age” or the “Company”) refers to the annual general
meeting to be held on 26 November 2025 (“AGM”). Battery Age issues an addendum notice of annual
general meeting and explanatory statement (“Addendum Notice”), setting out additional resolutions
which will be proposed at the AGM, together with a replacement proxy form (“Replacement Proxy
Form”).
The resolutions set out in this Addendum Notice should be read together with the original notice. Other
than as set out below, all details in relation to the original notice remain unchanged.
As permitted by the Corporations Act 2001 (Cth), the Addendum Notice is being made available to
shareholders by electronic means and the Company will not be dispatching physical copies of the
Addendum Notice, unless a shareholder has requested to receive a hard copy. Instead, the Addendum
Notice is available:
• at the Company’s website at https://batteryage.au/investors/asx-announcements/;
• via the Company’s ASX page at https://www2.asx.com.au/markets/company/bm8; and
• if you have nominated an email address and have elected to receive electronic communications
from the Company, via the electronic link that is sent to your nominated email address.
The Company strongly encourages shareholders to submit their Replacement Proxy Form to the
Company’s share registry, using any of the methods as detailed on the Proxy. Your proxy voting
instruction must be received by 10.30 am (AWST) on Monday, 24 November 2025 being not less than
48 hours before the commencement of the Meeting. Any proxy voting instructions received after that
time will not be valid for the Meeting.
Shareholders who have already lodged a proxy form for the Meeting and who do not lodge a
Replacement Proxy Form will be taken to have not voted on resolutions 8 to 10.
A copy of your personalised Replacement Proxy Form is enclosed for your reference. All resolutions will
be voted upon by poll.
In order to receive electronic communications from the Company in the future, please update your
Shareholder details online at www.investorcentre.com/au.
The Addendum Notice is important and should be read in its entirety. If shareholders are in doubt as to
how they should vote, they should seek advice from their professional advisers prior to voting. If you
have any difficulties obtaining a copy of the Addendum Notice please contact the Company’s share
registry, on, 1300 850 505 (within Australia) or +61 3 9415 4000 (overseas).
For more information on the Company, please refer to the Company’s website at: batteryage.au.
Yours faithfully
Battery Age Minerals Ltd
ASX: BM8
ACN 085 905 997
batteryageminerals.au
T: + 61 (8) 6109 6689
E: info@batteryage.au
Level 50, 108 St Georges Terrace
Perth, WA 6000
PO Box 7310, Cloisters Square
WA 6850
BATTERY AGE MINERALS LIMITED
ACN 085 905 997
ADDENDUM TO 2025 NOTICE OF ANNUAL GENERAL MEETING
Battery Age Minerals Limited ACN 085 905 997 (Company) hereby provides this Addendum
(Addendum) to the Notice of Annual General Meeting dated 28 October 2025 (Notice of
Meeting).
The Meeting will be held at 10:30am (AWST) on Wednesday, 26 November 2025 at the Boorloo
Meeting Room, Ground Floor, 108 St Georges Terrace, Perth, Western Australia, 6000.
Defined terms in the Notice of Meeting have the same meaning in this Addendum unless
otherwise stated.
This Addendum is supplemental to the original Notice of Meeting and should be read in
conjunction with the Notice of Meeting. Save for the amendments set out below, the Notice of
Meeting remains unchanged.
The numbering used in this Addendum is a continuation of the numbering used in the Notice of
Meeting.
This Addendum should be read in its entirety. If Shareholders are in doubt as to how they should
vote, they should seek advice from their suitably qualified professional advisors prior to voting.
ADDITIONAL RESOLUTIONS
By this Addendum:
• additional Resolution 8 to Resolution 10 (inclusive) as detailed below are added to the Notice
of Meeting and will be considered at the Meeting; and
• new Sections 11 to 14 (inclusive), amendments to the Definitions section and a new
Schedule 2 in respect of the additional Resolutions are added to the Explanatory
Memorandum in relation to the Notice of Meeting.
REPLACEMENT PROXY FORM
A replacement Proxy Form has been made available with this Addendum.
If Shareholders wish to have their votes counted by proxy in respect of Resolution 8 to Resolution
10 (inclusive), Shareholders must use the replacement Proxy Form to vote on ALL Resolutions. In
the event that a Shareholder provides a replacement Proxy Form, any Proxy Form dispatched
with the original Notice of Meeting which has been completed by that Shareholder will be
disregarded. If you have already voted and do not wish to vote on Resolution 8 to Resolution 10
(inclusive) or otherwise change your proxy vote, you do not need to take any action, as the
proxy you previously submitted remains valid.
The Company may accept Proxy Forms dispatched with the original Notice of Meeting received
from Shareholders in the event that a replacement Proxy Form is not provided by the relevant
Shareholder.
BY ORDER OF THE BOARD
Harry Spindler
Company Secretary
Battery Age Minerals Limited
Dated: 7 November 2025
Page 2
AGENDA
The following additional Resolutions are inserted in the Notice of Meeting as follows:
Resolution 8 – Ratification of agreement to issue Tranche 1 Placement Shares
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution, the
following:
‘That, pursuant to and in accordance with Listing Rule 7.4 and for all other purposes,
Shareholders ratify the issue of or agreement to issue up to 26,746,273 Tranche 1 Placement
Shares under Listing Rule 7.1, on the terms and conditions in the Explanatory Memorandum.’
Resolution 9 – Approval to issue Tranche 2 Placement Shares
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution, the
following:
‘That, pursuant to and in accordance with Listing Rule 7.1 and for all other purposes,
Shareholders approve the issue of up to 12,539,443 Tranche 2 Placement Shares, on the terms
and conditions in the Explanatory Memorandum.’
Resolution 10 – Approval to issue Broker Options
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution, the
following:
‘That, pursuant to and in accordance with Listing Rule 7.1 and for all other purposes, Shareholder
approve the issue of up to 3,000,000 Broker Options to the Joint Lead Managers (or their
respective nominees), on the terms and conditions in the Explanatory Memorandum.’
VOTING EXCLUSIONS
Pursuant to the Listing Rules, the Company will disregard any votes cast in favour of:
(a) Resolution 8: by or on behalf of a person who participated in the issue of the Tranche 1
Placement Shares, or is a counterparty to the agreement being approved, or any of their
respective associates, or any of their respective associates;
(b) Resolution 9: by or on behalf of any person who is expected to participate in, or who will
obtain a material benefit as a result of, the proposed issue of the Tranche 2 Placement
Shares (except a benefit solely by reason of being a Shareholder), or any of their
respective associates; and
(c) Resolution 10: by or on behalf of the Joint Lead Managers (or their respective nominees),
and any other person who will obtain a material benefit as a result of the proposed issue
of the Broker Options (except a benefit solely by reason of being a Shareholder), or any
of their respective nominees.
The above voting exclusions do not apply to a vote cast in favour of the relevant Resolution by:
(a) a person as proxy or attorney for a person who is entitled to vote, in accordance with
directions given to the proxy or attorney to vote on the Resolution in that way; or
(b) the Chair as proxy or attorney for a person who is entitled to vote, in accordance with a
direction given to the Chair to vote on the Resolution as the Chair decides; or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on
behalf of a beneficiary provided the following conditions are met:
(i) the beneficiary provides written confirmation to the holder that the beneficiary is
not excluded from voting, and is not an associate of a person excluded from
voting, on the Resolution; and
(ii) the holder votes on the Resolution in accordance with directions given by the
beneficiary to the holder to vote in that way.
Page 3
EXPLANATORY MEMORANDUM
The following new Sections, Definitions and an additional Schedule are added to the
Explanatory Memorandum in relation to the Notice of Meeting in respect of Resolution 8 to
Resolution 10 (inclusive) as follows:
11. Background to Resolution 8 to Resolution 10 (inclusive)
11.1 Placement
On 4 November 2025, the Company announced that it had received firm commitments
for a two-tranche placement to raise up to $5.5 million (before costs) via the issue of up
to 39,285,716 Shares (Placement Shares) at an issue price of $0.14 per Placement Share
(Placement).
The Placement is comprised of two tranches as follows:
(a) Tranche 1: 26,746,273 Placement Shares (Tranche 1 Placement Shares), which are
proposed to be issued on 17 November 2025 under Listing Rule 7.1 (the subject of
Resolution 8); and
(b) Tranche 2: subject to Shareholder approval at this Meeting, the proposed issue of
up to 12,539,443 Placement Shares (Tranche 2 Placement Shares) (the subject of
Resolution 9).
The Company engaged Euroz Hartleys Limited and 62 Capital Pty Ltd as joint lead
managers to the Placement (together, the Joint Lead Managers). As partial
consideration for the provision of joint lead managerial services in connection with the
Placement, the Joint Lead Managers (or their respective nominees) will be issued
3,000,000 unquoted Options, exercisable at $0.28 each, expiring on the date that is 3
years from the date of issue (Broker Options) (the subject of Resolution 10).
A summary of the Joint Lead Manager Mandate is set out in Section 11.2 below.
11.2 Summary of Joint Lead Manager Mandate
The Company entered into a mandate with the Joint Lead Managers for the provision of
joint lead managerial and bookrunner services, including the coordination and
management of the Placement (Joint Lead Manager Mandate).
Under the Joint Lead Manager Mandate, the Company has agreed to pay the following
fees to the Joint Lead Managers as consideration for its services:
(a) fees of 6% of the gross amount raised under the Placement; and
(b) the Broker Options,
with those fees split evenly between the Joint Lead Managers.
The Joint Lead Manager Mandate contains additional provisions, including warranties
and indemnities in respect of the Company which are considered standard for
agreements of this nature.
12. Resolution 8 – Ratification of agreement to issue Tranche 1 Placement Shares
12.1 General
The background to the Placement, including the proposed issue of the Tranche 1
Placement Shares is set out in Section 11.1 above.
Resolution 8 seeks the approval of Shareholders pursuant to Listing Rule 7.4 to ratify the
issue of or agreement to issue the Tranche 1 Placement Shares.
12.2 Listing Rule 7.1 and 7.4
Page 4
Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the
amount of Equity Securities that a listed company can issue without the approval of its
shareholders over any 12-month period to 15% of the fully paid ordinary shares it had on
issue at the start of that period.
The issue of or agreement to issue the Tranche 1 Placement Shares does not fit within any
of the exceptions to Listing Rule 7.1 and, as it has not yet been approved by Shareholders,
effectively uses up part of the Company’s 15% placement capacity under Listing Rule
7.1.
This reduces the Company’s capacity to issue further Equity Securities without
Shareholder approval under Listing Rule 7.1 for the 12-month period following the date
the Company agreed to issue the Tranche 1 Placement Shares.
Listing Rule 7.4 provides an exception to Listing Rule 7.1. It provides that where a company
in a general meeting ratifies the previous issue of securities after it has been made or
agreed to be made pursuant to Listing Rule 7.1 (and provided that the previous issue did
not breach Listing Rule 7.1), those securities will be deemed to have been made with
shareholder approval for the purpose of Listing Rule 7.1.
The effect of Shareholders passing Resolution 8 will be to allow the Company to retain
the flexibility to issue Equity Securities in the future up to the 15% placement capacity set
out in Listing Rule 7.1, without the requirement to obtain prior Shareholder approval.
If Resolution 8 is passed and the Company issues up to 26,746,273 Tranche 1 Placement
Shares under Listing Rule 7.1 no later than 3 months after the date of the Meeting, the
agreement to issue (and the issue itself) will be excluded in calculating the Company’s
15% limit under Listing Rule 7.1, effectively increasing the number of Equity Securities it
can issue or agree to issue without Shareholder approval over the 12-month period
following the agreement to issue the Tranche 1 Placement Shares.
If Resolution 8 is not passed, 26,746,273 Tranche 1 Placement Shares will continue to be
included in calculating the Company’s 15% limit under Listing Rule 7.1, effectively
decreasing the number of Equity Securities the Company can issue or agree to issue
without obtaining prior Shareholder approval, to the extent of 26,746,273 Equity Securities
for the 12-month period following the agreement to issue those Tranche 1 Placement
Shares.
12.3 Specific information required by Listing Rule 7.5
Subject to and in accordance with Listing Rule 7.5, the following information is provided
in relation to the ratification of the issue of or agreement to issue the Tranche 1 Placement
Shares:
(a) The Company has agreed to issue the Tranche 1 Placement Shares to a range of
new and existing sophisticated and professional investors (Tranche 1 Placement
Participants), none of whom are a related party of the Company or Material
Investor. The Tranche 1 Placement Participants were identified through a
bookbuild process, which involved the Joint Lead Managers seeking expressions
of interest to participate in the Placement from new and existing contacts of the
Company and clients of the Joint Lead Managers.
(b) A maximum of 26,746,273 Tranche 1 Placement Shares were agreed to be issued
within the Company’s 15% placement capacity permitted under Listing Rule 7.1.
(c) The Tranche 1 Placement Shares will be fully paid ordinary shares in the capital of
the Company and rank equally in all respects with the Company’s existing Shares
on issue.
(d) The Tranche 1 Placement Shares are expected to be issued on 17 November 2025,
and in any event no later than 3 months after the date of the Meeting.
(e) The Tranche 1 Placement Shares will be issued at an issue price of $0.14 each.
Page 5
(f) The proceeds from the Placement are intended to be applied towards:
(i) ongoing drilling at the Bleiberg Zinc–Lead–Germanium Project (Austria);
(ii) maiden drilling at the El Aguila Gold–Silver Project (Argentina);
(iii) exploration commencement at the Apex Germanium–Gallium Project
(USA);
(iv) University of Sydney research program on germanium recovery
techniques; and
(v) working capital, corporate costs, and associated offer expenses.
(g) There are no other material terms to the agreement for subscription of the Tranche
1 Placement Shares.
(h) A voting exclusion statement is included in the Notice.
12.4 Additional information
Resolution 8 is an ordinary resolution.
The Board recommends that Shareholders vote in favour of Resolution 8.
13. Resolution 9 – Approval to issue Tranche 2 Placement Shares
13.1 General
The background to the Placement, including the proposed issue of the Tranche 2
Placement Shares is set out in Section 11.1 above.
Resolution 9 seeks the approval of Shareholders pursuant to Listing Rule 7.1 for the issue
of the Tranche 2 Placement Shares.
13.2 Listing Rule 7.1
A summary of Listing Rule 7.1 is set out in Section 12.2 above.
The proposed issue of the Tranche 2 Placement Shares does not fit within any of the
exceptions to Listing Rule 7.1 and exceeds the Company’s 15% placement capacity
under Listing Rule 7.1. It therefore requires the approval of Shareholders under Listing Rule
7.1.
The effect of Shareholders passing Resolution 9 will be to allow the Company to retain
the flexibility to issue Equity Securities in the future up to the 15% placement capacity set
out in Listing Rule 7.1, without the requirement to obtain prior Shareholder approval.
If Resolution 9 is passed, the Company will be able to proceed with the issue of up to
12,539,443 Tranche 2 Placement Shares and raise up to approximately $1.75 million
(before costs). In addition, the issue of the Tranche 2 Placement Shares will be excluded
in calculating the Company’s 15% limit in Listing Rule 7.1, effectively increasing the
number of Equity Securities it can issue or agree to issue without Shareholder approval
over the 12-month period following the issue date.
If Resolution 9 is not passed, the Company will not be able to proceed with the issue of
up to 12,539,443 Tranche 2 Placement Shares and will not be able to raise the additional
$1.75 million (before costs) from the issue of the Tranche 2 Placement Shares.
13.3 Specific information required by Listing Rule 7.3
Pursuant to and in accordance with Listing Rule 7.3, the following information is provided
in relation to the proposed issue of the Tranche 2 Placement shares:
(a) The Tranche 2 Placement Shares will be issued to a range of new and existing
sophisticated and professional investors (Tranche 2 Placement Participants), none
Page 6
of whom are a related party of the Company. The Tranche 2 Placement
Participants were identified through a bookbuild process, which involved the Joint
Lead Managers seeking expressions of interest to participate in the Placement
from new and existing contacts of the Company and clients of the Joint Lead
Managers.
In accordance with paragraph 7.2 of ASX Guidance Note 21, the Company
advises that Mr Sufian Ahmad (and his associates), a Material Investor, will be
issued 3,214,286 Tranche 2 Placement Shares which constitutes more than 1% of
the Company’s current issued capital. 62 Capital Pty Ltd, being one of the Joint
Lead Managers engaged by the Company, is a company controlled by Mr
Ahmad.
Other than as set out above, none of the other Tranche 2 Placement Participants
are a Material Investor.
(b) A maximum of 12,539,443 Tranche 2 Placement Shares will be issued.
(c) The Tranche 2 Placement Shares will be fully paid ordinary shares in the capital of
the Company and rank equally in all respects with the Company’s existing Shares
on issue.
(d) The Tranche 2 Placement Shares will be issued no later than 3 months after the
date of the Meeting.
(e) The Tranche 2 Placement Shares will be issued at an issue price of $0.14 each,
being the same price at which the Tranche 1 Placement Shares were agreed to
be issued.
(f) A summary of the intended use of funds raised from the Placement is set out in
Section 12.3(f) above.
(g) There are no other material terms to the agreement for the issue of the Tranche 2
Placement Shares.
(h) A voting exclusion statement is included in this Notice.
13.4 Additional information
Resolution 9 is an ordinary resolution.
The Board recommends that Shareholders vote in favour of Resolution 9.
14. Resolution 10 – Approval to issue Broker Options
14.1 General
The background to the Placement, including the proposed issue of the Broker Options is
set out in Section 11.1 above.
Resolution 10 seeks approval of Shareholders pursuant to Listing Rule 7.1 for the issue of
the Broker Options to the Joint Lead Managers (or their respective nominees).
14.2 Listing Rule 7.1
A summary of Listing Rule 7.1 is set out in Section 12.2 above.
The proposed issue of the Broker Options does not fit within any of the exceptions to Listing
Rule 7.1 and exceeds the Company’s 15% placement capacity under Listing Rule 7.1. It
therefore requires the approval of Shareholders under Listing Rule 7.1.
The effect of Shareholders passing Resolution 10 will be to allow the Company to retain
the flexibility to issue Equity Securities in the future up to the 15% placement capacity set
Page 7
out in Listing Rule 7.1, without the requirement to obtain prior Shareholder approval.
If Resolution 10 is passed, the Company will be able to proceed with the issue of up to
3,000,000 Broker Options to the Joint Lead Managers (or their respective nominees). In
addition, the issue of the Broker Options will be excluded in calculating the Company’s
15% limit in Listing Rule 7.1, effectively increasing the number of Equity Securities it can
issue or agree to issue without Shareholder approval over the 12-month period following
the issue date.
If Resolution 10 is not passed, the Company will not be able to proceed with the issue of
up to 3,000,000 Broker Options to the Joint Lead Managers (or their respective nominees)
and will have to consider other forms of remuneration for the Joint Lead Managers.
14.3 Specific information required by Listing Rule 7.3
Pursuant to and in accordance with Listing Rule 7.3, the following information is provided
in relation to the proposed issue of the Broker Options:
(a) The Broker Options will be issued to the Joint Lead Managers (or their respective
nominees), none of whom are a related party of the Company.
(b) A maximum of 3,000,000 Broker Options will be issued.
(c) The Broker Options will be exercisable at $0.28 each, expiring 3 years from the date
of issue and otherwise subject to the terms and conditions in Schedule 2
(d) The Broker Options will be issued no later than 3 months after the date of the
Meeting.
(e) The Broker Options will be issued for a nominal price of $0.00001 each, as partial
consideration for the provision of joint lead manager services pursuant to the
terms of the Joint Lead Manager Mandate. Accordingly, only a nominal amount
of $200 will be raised by the issue of the Broker Options, which will be used for
general working capital purposes.
(f) A summary of the material terms of the Joint Lead Manager Mandate is set out in
Section 11.2 above.
(g) A voting exclusion statement is included in this Notice.
14.4 Additional information
Resolution 10 is an ordinary resolution.
The Board recommends that Shareholders vote in favour of Resolution 10.
Page 8
ADDITIONAL DEFINITIONS
Addendum means this addendum to the Notice of Meeting.
Broker Options has the meaning given in Section 11.1.
Joint Lead Manager Mandate has the meaning given in Section 11.2.
Joint Lead Managers means, collectively, Euroz Hartleys Limited and 62 Capital Pty
Ltd.
Material Investor means, in relation to the Company:
(a) a related party;
(b) Key Management Personnel;
(c) a substantial Shareholder;
(d) an advisor; or
(e) an associate of the above,
who received Securities in the Company which constitute
more than 1% of the Company's capital structure at the time
of agreement to issue.
Placement has the meaning given in Section 11.1.
Placement Shares has the meaning given in Section 11.1.
Tranche 1 Placement
Participants
has the meaning given in Section 12.3(a).
Tranche 1 Placement Shares has the meaning given in Section 11.1(a).
Tranche 2 Placement
Participants
has the meaning given in Section 13.3(a).
Tranche 2 Placement Shares has the meaning given in Section 11.1(b).
Page 9
Schedule 2 Terms and conditions of Broker Options
The terms and conditions of the Broker Options (in this Schedule, referred to as Options) are as
follows:
1. (Entitlement): Each Option entitles the holder to subscribe for one Share upon exercise of
the Option.
2. (Issue Price): Each Option will have a nominal issue price of $0.00001.
3. (Exercise Price and Expiry Date): the amount payable upon exercise of each Option is
$0.28 each (Exercise Price), and the expiry date of each Option is 3 years from the date
of issue (Expiry Date).
4. (Exercise Period): The Options are exercisable at any time on or prior to the Expiry Date.
5. (Quotation of the Options): The Company will not apply for quotation of the Options on
any securities exchange.
6. (Transferability): The Options are not transferable.
7. (Notice of Exercise): The Options may be exercised by notice in writing to the Company
in the manner specified on the Option certificate (Notice of Exercise) and, if applicable,
payment of the Exercise Price for each Option being exercised in Australian currency by
electronic funds transfer or other means of payment acceptable to the Company.
Any Notice of Exercise of an Option received by the Company will be deemed to be a
notice of the exercise of that Option as at the date of receipt of the Notice of Exercise
and, if applicable, the date of receipt of the payment of the Exercise Price for each
Option being exercised in cleared funds (Exercise Date).
8. (Timing of issue of Shares on exercise): Within 5 Business Days of receipt of the Exercise
Notice accompanied by the Exercise Price, the Company will subject to paragraphs 9
and 11:
(a) allot and issue the number of Shares required under these terms and conditions in
respect of the number of Options specified in the Notice of Exercise and for which,
if applicable, cleared funds have been received by the Company;
(b) if required, give ASX a notice that complies with section 708A(5)(e) of the
Corporations Act; and
(c) do all such acts, matters and things to obtain the grant of quotation of the Shares
by ASX in accordance with the Listing Rules.
9. (Restrictions on transfer of Shares): If the Company is unable to give ASX a notice that
complies with section 708A(5)(e) of the Corporations Act, or such a notice for any reason
is not effective to ensure that an offer for sale of the Shares does not require disclosure to
investors, Shares issued on exercise of the Options may not be traded until 12 months
after their issue unless the Company, at its sole discretion, elects to issue a prospectus
pursuant to section 708A(11) of the Corporations Act. The Company is authorised by the
holder to apply a holding lock on the relevant Shares during the period of such restriction
from trading.
10. (Shares issued on exercise): Shares issued on exercise of the Options rank equally with
the then issued shares of the Company.
11. (Takeovers prohibition):
(a) the issue of Shares on exercise of the Options is subject to and conditional upon
the issue of the relevant Shares not resulting in any person being in breach of
section 606(1) of the Corporations Act; and
(b) the Company will not be required to seek the approval of its members for the
purposes of item 7 of section 611 of the Corporations Act to permit the issue of
any Shares on exercise of the Options.
Page 10
12. (Reconstruction of capital): If at any time the issued capital of the Company is
reconstructed, all rights of an Option holder are to be changed in a manner consistent
with the Corporations Act and the Listing Rules at the time of the reconstruction.
13. (Participation in new issues): There are no participation rights or entitlements inherent in
the Options and holders will not be entitled to participate in new issues of capital offered
to Shareholders during the currency of the Options without exercising the Options.
14. (Entitlement to dividends): The Options do not confer any entitlement to a dividend,
whether fixed or at the discretion of the directors, during the currency of the Options
without exercising the Options.
15. (Entitlement to capital return): The Options do not confer any right to a return of capital,
whether in a winding up, upon a reduction of capital or otherwise, and similarly do not
confer any right to participate in the surplus profit or assets of the Company upon a
winding up, in each case, during the currency of the Options without exercising the
Options.
16. (Adjustments for reorganisation): If there is any reorganisation of the issued share capital
of the Company, the rights of the Option holder will be varied in accordance with the
Listing Rules.
17. (Adjustment for bonus issues of Shares): If the Company makes a bonus issue of Shares or
other securities to existing Shareholders (other than an issue in lieu or in satisfaction of
dividends or by way of dividend reinvestment):
(a) the number of Shares which must be issued on the exercise of an Option will be
increased by the number of Shares which the Option holder would have received
if the Option holder had exercised the Option before the record date for the
bonus issue; and
(b) no change will be made to the Exercise Price.
18. (Voting rights): The Options do not confer any right to vote at meetings of members of
the Company, except as required by law, during the currency of the Options without first
exercising the Options.
19. (No other rights): An Option does not give a holder any rights other than those expressly
provided by these terms and those provided at law where such rights at law cannot be
excluded by these terms.
20. (Amendments required by ASX): The terms of the Options may be amended as
considered necessary by the Board in order to comply with the Listing Rules, or any
directions of ASX regarding the terms provided that, subject to compliance with the
Listing Rules, following such amendment, the economic and other rights of the holder
are not diminished or terminated.
21. (Constitution): Upon the issue of Shares on exercise of the Options, the holder agrees to
be bound by the Company’s constitution
SRN/HIN: I9999999999
XX
For your proxy appointment to be effective it
must be received by 10:30am (AWST) on
Monday, 24 November 2025.
All your securities will be voted in accordance with your direc
Share your feedback
Discover